How CROs Are Proving the Anti-Cancer Properties of Beta-Blockers Through Clinical Research

If you take Propranolol, a beta-blocker commonly used to treat anxiety disorders, you’ll be pleased to know that a new clinical study has suggested its ability to prevent cancer. Existing animal and human data has already hinted at the drug’s success in treating a number of tumour types, but this pioneering clinical research indicates that it could contain cancer-fighting properties, too.

The beta-blocker has been used to treat ‘infantile haemangiomas’ (benign tumours in children) since the 1960s. Since then, medical scientists all over the world have suspected that this egularly prescribed drug could have other beneficial properties, as well as treating anxiety, and conditions which affect the heart rate.

But this new evidence as to the drug’s ability to prevent cancer in our body’s cells could be life-changing for people all over the world. With almost 1000 cases being diagnosed every day in the UK alone and only 50% surviving the illness, it’s high time we had a breakthrough in the search for a cure.

If you take these beta-blockers, you will already know that they’re one of the safest drugs on the market. Not only are they cheap, but they’re incredibly effective at treating conditions that raise your heart rate above optimum levels – hence their ability to prevent and treat panic attacks in anxiety sufferers.

It’s not surprising then, that the drug has been found to provide a particularly effective solution for Angiosarcoma – a rare form of cancer that affects the heart. This is a rare disease which doesn’t attract much attention from commercial drug developers. But if you know someone who has been affected, you’ll know that, like all cancers, it is in desperate need of a cure.

The toxicity levels of the drug are also incredibly low, so much so that they’re almost non-existent. Generally, this indicates that even by taking it for a prolonged period,you’re not likely to cause lasting damage to your gut or liver. Like any medication though, it provokes different reactions in different individuals, and you should consult your doctor before taking it.

Pharmaceutical companies famously don’t devote much time or research into, what scientists call, ‘repurposing’ existing drugs. But this could well be an oversight on their part. Organisations such as ReDO – The Repurposing Drugs in Oncology project – are hoping to change that. They are sharing their evidence through a series of articles, also in ecancer magazine, if you’re keen to find out more.

Propranolol is also on the WHO List of Essential Medicines, suggesting that non-cancer related drugs might perversely be the solution to cancer. Just to add to its life-changing assets, the evidence surrounding this case study into Propranolol has also advised that it could prevent ‘metastatic cascade’ – a global phenomenon affecting many cancer patients.

Metastatic cascade is the spreading of cancer cells to other areas of the body, and is unfortunately common in patients post-surgery. This is a revolutionary step forwards for medicine, as preventing the spread of cancer could ultimately save millions of lives.

These beta-blockers are also available globally, so patients will not have to travel to receive treatment, like with so many alternative treatments for cancer.

Once again, you should only ever take Propranolol if it has been prescribed by your GP or health physician. Like every prescription drug, it can cause side effects, and also be potentially harmful if mixed with other medications, so you should never take it without consulting a doctor or pharmacist first.

The evidence backing up this latest research is compelling and suggestive of ground-breaking advances in modern medicine. If you want to know more, you can read the clinical study, recently published in ecancer, a medical science magazine.

Comments are closed.